Exponential Biotherapies, Inc.
Hospitals and Health CareVirginia, United States2-10 Employees
Exponential Biotherapies, Inc. is a Biotechnology company located in McLean, Virginia, United States.
Innovative Therapy Focus Exponential Biotherapies is developing EA-230, a novel immunomodulatory peptide derived from the human pregnancy hormone, indicating a strong focus on cutting-edge biotech therapeutics with potential interest from healthcare providers seeking advanced treatment options.
Funding & Growth Potential With $11 million in funding despite current revenues below 1 million dollars, the company may be seeking strategic partnerships or additional investment to accelerate development and commercialization efforts.
Technology Integration Utilizing a diverse tech stack, including Varnish, MySQL, and JSON-LD, suggests the company values robust data management and digital outreach, offering opportunities to collaborate on digital health solutions or data-driven marketing.
Market Positioning Operating in the competitive biotech space alongside firms like Vertex and Moderna, Exponential Biotherapies could benefit from partnerships with established players for technology sharing, distribution, or clinical development support.
Small but Niche As a small team with 2-10 employees, the company is likely agile and open to strategic alliances that can help scale operations or bring their innovative therapeutics to the market faster, making it a prime candidate for early-stage collaboration opportunities.
Exponential Biotherapies, Inc. uses 8 technology products and services including Varnish, MySQL, oEmbed, and more. Explore Exponential Biotherapies, Inc.'s tech stack below.
| Exponential Biotherapies, Inc. Email Formats | Percentage |
| First@exponential.org | 100% |
Hospitals and Health CareVirginia, United States2-10 Employees
Exponential Biotherapies, Inc. is a Biotechnology company located in McLean, Virginia, United States.
Exponential Biotherapies, Inc. has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Jan 31, 2007 in the amount of $11M.
Exponential Biotherapies, Inc.'s revenue is estimated to be in the range of $1M
Exponential Biotherapies, Inc. has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Jan 31, 2007 in the amount of $11M.
Exponential Biotherapies, Inc.'s revenue is estimated to be in the range of $1M